Brief: Boiron: HAS Maintains Unfavorable Opinion Regarding Reimbursement Of Homeopathic Medicines
June 28 (Reuters) - BOIRON SA BOIR.PA :
* HAUTE AUTORITE DE SANTE (HAS) HAS MAINTAINED ITS
UNFAVORABLE
OPINION REGARDING THE REIMBURSEMENT OF HOMEOPATHIC MEDICINES
* SAYS 60% OF THE ACTIVITY OF THE BOIRON GROUP WOULD BE
DIRECTLY
AFFECTED BY A CHANGE OF THE REIMBURSEMENT RATE OF HOMEOPATHIC
MEDICINES urn:newsml:reuters.com:*:nFWN23Y17B
Source text for Eikon: urn:newsml:reuters.com:*:nACT59039
Further company coverage: BOIR.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920))
Recent news on Boiron SA
See all newsBrief: Boiron FY Revenue EUR 501.11 Mln, Proposes Dividend Of EUR 1.35 Per Share
Brief: Boiron Signs Agreement With Panaxia Malta For Research And Development Of Cannabis For Medical Use
Brief: Thierry Boiron Steps Down As Deputy CEO Of Boiron SA
Brief: Boiron H1 Net Income Group Part EUR 11.4 Mln
Brief: Euronext: Quarterly Review Of CAC Family